Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEdmund Optics:Edmund Optics: Minimize Ultrafast Pulse Spreading with Low Group Delay Dispersion Optics

Edmund Optics: Minimize Ultrafast Pulse Spreading with Low Group Delay Dispersion Optics

Edmund Optics, a leading global manufacturer and supplier of optical components, now internally manufactures short pulse optics with low group delay dispersion (GDD) out of Edmund Optics Florida, formerly known as Quality Thin Films (QTF). These optics minimize chromatic aberration and pulse spreading in ultrafast laser systems, resulting in higher peak powers.

Minimize Ultrafast Pulse Spreading with Low Group Delay Dispersion Optics
Edmund Optics®, leading global manufacturer and supplier of optical components, now internally manufactures short pulse optics with low group delay dispersion (GDD) out of Edmund Optics Florida, formerly known as Quality Thin Films (QTF).

Before being acquired by Edmund Optics, Quality Thin Films (QTF), a leading laser optics manufacturer, had the ability to design and coat low GDD optics, though they lacked the metrology required to verify the specifications. Customer feedback showed that the optics performed well, but this could not be confirmed in-house. Edmund Optics uses white light interferometers and an in-house ultrafast laser to measure GDD, allowing measurement of these challenging optics to verify their performance in real environments.

Low GDD optics from Edmund Optics Florida are measured before they are shipped, guaranteeing GDD specifications from 250 to 3,200 nm within +- 10 fs². Whether you require low GDD mirrors, filters, or other ultrafast optics, Edmund Optics has the manufacturing and metrology technology to create a solution for you.

Edmund Optics Florida excels in manufacturing a wide variety of laser optics including laser crystals, high laser-induced damage threshold optics, and now low GDD optics.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy